Syncona Portfolio Ltd Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001725042

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 1 positions · Total reported value $26.63M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Syncona Portfolio Ltd disclosed 1 equity positions with a combined reported value of $26.63M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were AUTL ($26.63M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Syncona Portfolio Ltd opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 50% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were IPSC ($2.74M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • IPSC CENTURY THERAPEUTICS INC · prev qtr: $2.74M

Insider Transactions (Form 4)

Latest Syncona Portfolio Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Syncona Portfolio Ltd is an SEC-registered 13F filer. As of Q2 2026 it reported 1 US equity positions with a combined value of $26.63M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 1 positions · $26.63M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: AUTL (AUTOLUS THERAPEUTICS LTD) at 100.0%
  • Average position size: $26.63M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The Syncona Portfolio Ltd did not change its holdings in the second quarter of 2026, indicating a conservative stance with a preference for maintaining current positions rather than reallocating capital based on market movements. 2. Key Moves: There were no new additions to the portfolio, and no holdings were reduced. The total value of the portfolio remained at $26.6 million, with the existing position in AUTOLUS THERAPEUTICS LTD unchanged. 3. Portfolio Structure: The portfolio is likely to be classified as passive, given the lack of changes in holdings. The sector bias is toward Health Care, as evidenced by the significant position in AUTOLUS THERAPEUTICS LTD. The risk appetite appears moderate, as the fund did not increase exposure to potentially higher-risk sectors or assets. 4. Per-Holding One-Liner: - AUTL (AUTOLUS THERAPEUTICS LTD): A biotechnology company focused on developing novel cell therapies for cancer. 'Verified' 5. One-Sentence Style Summary: Syncona Portfolio Ltd maintained a stable, passive approach in Q2 2026, focusing on a single Health Care holding and demonstrating a cautious, sector-concentrated investment strategy.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 16.64M $26.63M 100.00%
100.00%
Hold

FAQ

What did Syncona Portfolio Ltd buy in 2026-Q2?

In its 2026-Q2 13F filing, Syncona Portfolio Ltd reported 1 equity positions worth $26.63M in aggregate; its largest disclosed positions were AUTL ($26.63M).

How large is Syncona Portfolio Ltd's portfolio?

Syncona Portfolio Ltd reported $26.63M of long equity holdings across 1 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Syncona Portfolio Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/syncona-portfolio/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →